Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Krause Allyson G.General Counsel | Grant or award | A | $1.01M 2.66M sh | Jul 7, 2026 |
| 36 | Giterman Arthur G.Director, CEO and CFO | Grant or award | A | $2.70M 7.09M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 36 | Liu YingDirector | Grant or award | A | — 123.8K sh | Jul 7, 2026 traded May 22, 2026 |
| 36 | Barak MariaChief Accounting Officer | Open-market sale | SELL | $23K 1,747 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 35 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $2.08M 10.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Solomon Lance I.Chief Product Officer | Grant or award | A | $442K 1.16M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Strand Michael B.Chief Revenue Officer | Grant or award | A | $351K 923.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $329K 41.3K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 32 | Skynner MichaelCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $2,293 532 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | Open-market sale | SELL | $1,099 255 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Lee KevinDirector, CHIEF EXECUTIVE OFFICER | Open-market sale | SELL | $7,486 1,737 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $387K 2,009 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 32 | Thompson Travis AlvinChief Financial Officer | Open-market sale | SELL | $448 104 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 31 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $1.37M 7,206 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $5.20M 239.4K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Merle Denise MDirector | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $3.30M 146.9K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Mendelson RobinDirector | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Getz Joel A.Director | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Leung Lim Kin SimonDirector | Grant or award | A | $225K 592.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Lechleider RobertChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $377K 16.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 35 | Moore Daniel WilliamPFO and PAO | Open-market sale | SELL | $159K 7,085 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 30 | Kleinerman ChristianEVP, Product Management | Open-market sale · 10b5-1 plan | SELL | $646K 2,500 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 30 | Oman David WChief Risk Officer | Tax withholding | F | $142K 1,357 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 56 | Gamboni Francesca Paola LeandraDirector | Open-market purchase | BUY | $30K 1,709 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 56 | Zhang Quan (Joe)Director | Open-market purchase | BUY | $30K 1,700 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 33 | Casey Patrick JohnDirector | Open-market sale | SELL | $89K 6,000 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $2.15M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $3.17M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $3.17M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $3.14M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $3.14M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $2.15M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $2.13M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $2.13M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 52 | Shen XiaojieDirector | Open-market purchase | BUY | $42K 2,436 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer | Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 47 | Vahland WinfriedDirector | Open-market purchase | BUY | $102K 6,000 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 45 | Tpg Gp A, Llc10% Owner | NATPG Twin Brook Capital Income Fund Open-market purchase | BUY | $100.00M 3.97M sh | Jul 1, 2026 traded Jun 29, 2026 |
| 42 | Menell Richard PeterDirector | Open-market purchase | BUY | $33K 15.0K sh | Jul 1, 2026 traded Jun 30, 2026 |